NEW YORK (GenomeWeb) – Intrexon today said that it completed a public offering that raised $230 million in gross proceeds. 

The firm sold 5,609,756 shares of its common stock at $41 per share, which included 731,707 shares purchased by the offering's underwriters under an option granted to them by Intrexon. 

JMP Securities was the sole book-running manager while Stifel was the lead manager on the offering. Griffin Securities and Wunderlich Securities were the co-managers. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.